|
|
Last Modified: 12/20/2006  First Published: 2/21/2003 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
Under 80
|
|
|
|
Other
|
|
|
|
FRE-FNCLCC-GETUG-12/0203 EU-20238, NCT00055731
|
|
|
|
|
|
|
|
Last Modified: 5/14/2008  First Published: 2/18/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
Under 75
|
|
|
|
Other
|
|
|
|
FRE-FNCLCC-GETUG-14/0207 EU-20503, NCT00104741
|
|
|
|
|
|
|
|
Last Modified: 1/13/2009  First Published: 1/25/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
RTOG-0521 NCT00288080
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
Not specified
|
|
|
|
Other
|
|
|
|
2003-0819 NCT00388804
|
|
|
|
|
|
|
|
Last Modified: 1/11/2009  First Published: 12/3/2007 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
RTOG-0534 RTOG 0534, NCT00567580
|
|
|
|
|
|
|
|
Last Modified: 1/6/2009  First Published: 3/31/2008 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
Not specified
|
|
|
|
NCI
|
|
|
|
CAN-NCIC-PR12 PR12, NCT00651326
|
|
|
|
|
|
|
|
Last Modified: 12/8/2008  First Published: 1/24/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
Over 18
|
|
|
|
Other
|
|
|
|
MUSC-031218 100822, MUSC-HR-11357, NCT00103376
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
R04-0092 NCT00138918
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
over 21
|
|
|
|
Other
|
|
|
|
06-2040-A-02 L-8863, NCT00223665
|
|
|
|
|
|
|
|
Last Modified: 8/29/2008  First Published: 3/16/2007 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Biomarker/Laboratory analysis, Treatment
|
|
|
|
Active
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
NCI-07-C-0107 07-C-0107, 7354, NCT00450463
|
|
|
|